mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.011 |
0.9 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.9 |
mRNA |
BRD-K27224038 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.9 |